Cytomegalovirus human immunoglobulin intravenous (Chengdu Rongsheng Pharmaceuticals)
巨细胞病毒人免疫球蛋白（pH4）（成都蓉生药业）
Report date: 2024/03/12 20:00:43
Base Information
Drug NameCytomegalovirus human immunoglobulin intravenous (Chengdu Rongsheng Pharmaceuticals)
Drug Alias Name
Classification
Mechanisms of Action
Targets
Therapy Area/Indications
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/Territory
CombinationsNo
Global Highest StatusDiscontinued (Phase 3 Clinical)
Highest Status in ChinaDiscontinued
Originator CompaniesChengdu Rongsheng Pharmaceuticals Co Ltd
China Registration ClassN/A
Develop Information
Active CompaniesN/A
Inactive CompaniesChengdu Rongsheng Pharmaceuticals Co Ltd
Active IndicationsN/A
Inactive Indications
Other Information
ATC CodeN/A
Related LinksN/A